Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Female × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 122 Prostatic Neoplasms 28 Breast Neoplasms 28 Insulin Resistance 26 Obesity 14 Pancreatic Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Endometrial Neoplasms 11 Neoplasms 10 Infertility 10 Colorectal Neoplasms 10 Anovulation 9 Lung Neoplasms 8 Metabolic Syndrome 7 Glioblastoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Melanoma 6 Hyperandrogenism 6 Diabetes Mellitus 6 Adenocarcinoma 5 Weight Loss 4 Rectal Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Head and Neck Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Urinary Bladder Neoplasms 3 Recurrence 3 Ovarian Neoplasms 3

Interventions

Metformin 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05292573 2022-03-23

Longitudinal Follow-up in Women With Endometrial Hyperplasia Without Atypia

Chang Gung Memorial Hospital

Phase 3 Unknown

Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡